Arkstone, an innovative biotechnology company democratizing infectious disease expertise and fighting antimicrobial resistance, has been acquired by global healthcare private equity firm ARCHIMED, which...
Marvin Ellison and Don Thompson Headline the NBMBAA's 47th Annual Conference & Career Expo Centered on Wealth Building, Leadership, AI, and Tech Innovation
ATLANTA, July...
b.well's FHIR-based infrastructure, semantic interoperability capabilities, and consumer-centered user experience align with CMS's vision for modern healthcare data exchange
BALTIMORE, July 30, 2025 /PRNewswire/ --...
TOKYO and CAMBRIDGE, Mass., July 30, 2025 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, “Biogen”) announced today that the two-year real-world study in the U.S of lecanemab (generic name, product name: LEQEBMI®), an anti-Aβ protofibril* antibody, was presented at the Alzheimer's Association International Conference (AAIC) 2025, held in Toronto, Canada and virtually. Only lecanemab fights AD in two ways – targeting both amyloid plaque and protofibrils*, which can impact tau downstream.
ANN ARBOR, Mich., July 30, 2025 /PRNewswire/ -- Espervita Therapeutics, a biotechnology company developing targeted metabolic reprogramming therapies, announced the publication in Nature featuring groundbreaking...
-Company expects to initiate Phase 2 study in 2H 2025-
SAN DIEGO, July 30, 2025 /PRNewswire/ -- EuMentis Therapeutics, Inc., ("EuMentis"), a clinical-stage drug development company...
BOSTON, July 30, 2025 /PRNewswire/ -- LearnLux, the leading workplace financial wellbeing provider, is proud to celebrate the fifth anniversary and continued success of...
The Hydrogen Peroxide Market presents strong growth opportunities driven by eco-conscious demand from pulp & paper, wastewater treatment, and healthcare sectors. However, safety, storage, and...
The Anime market is anticipated to increase due to rapidly expanding international fanbase, especially among Gen Z and millennials. Increased accessibility through streaming platforms...
The Hydrogen Peroxide Market presents strong growth opportunities driven by eco-conscious demand from pulp & paper, wastewater treatment, and healthcare sectors. However, safety, storage, and...
SALT LAKE CITY, July 30, 2025 /PRNewswire/ -- FatPipe, Inc. (NASDAQ: FATN) ("FatPipe" or the "Company"), a pioneer in enterprise-class, application-aware, secure software-defined wide area...